Fortrea Stock Price, News & Analysis (NASDAQ:FTRE) $30.94 -0.70 (-2.21%) (As of 12/5/2023 ET) Add Compare Share Share Today's Range$30.70▼$31.4650-Day Range$27.12▼$33.5552-Week Range$24.92▼$37.30Volume531,961 shsAverage Volume1.73 million shsMarket Capitalization$2.75 billionP/E RatioN/ADividend YieldN/APrice Target$33.25 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media About Fortrea Stock (NASDAQ:FTRE)Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. It offers phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. is based in Durham, North Carolina.Read More FTRE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FTRE Stock News HeadlinesDecember 3, 2023 | americanbankingnews.comEvercore ISI Upgrades Fortrea (NASDAQ:FTRE) to OutperformDecember 3, 2023 | americanbankingnews.comFortrea (NASDAQ:FTRE) Shares Gap Up to $29.44December 6, 2023 | Edge On The Street (Ad)Energy Storage Trend Ignites Frenzy Over Vanadium SupplyAs the world shifts to renewables such as wind and solar, how will we store all this energy? Vanadium batteries are the breakthrough that some experts predict will be the future of grid-scale energy storage. The problem is, only 5% of vanadium is mined in the U.S. - and China and Russia have a stranglehold on our supply.December 1, 2023 | realmoney.thestreet.comFortrea Holdings upgraded to Outperform from In Line at Evercore ISIDecember 1, 2023 | markets.businessinsider.comThe Latest Analyst Ratings for Fortrea HoldingsNovember 28, 2023 | markets.businessinsider.comWhy Is Inflammation Disease Focused Acelyrin Stock Trading Lower Today?November 14, 2023 | msn.comFortrea upgraded at Barclays after Q3 beatNovember 14, 2023 | seekingalpha.comFortrea Holdings Q3 Earnings: A Very Mixed BagDecember 6, 2023 | Edge On The Street (Ad)Energy Storage Trend Ignites Frenzy Over Vanadium SupplyAs the world shifts to renewables such as wind and solar, how will we store all this energy? Vanadium batteries are the breakthrough that some experts predict will be the future of grid-scale energy storage. The problem is, only 5% of vanadium is mined in the U.S. - and China and Russia have a stranglehold on our supply.November 13, 2023 | finance.yahoo.comFortrea Holdings Inc (FTRE) Reports Mixed Q3 Results Amidst TransformationNovember 13, 2023 | finanznachrichten.deFortrea Holdings Inc: Fortrea Reports Third Quarter 2023 ResultsNovember 13, 2023 | finance.yahoo.comFortrea Reports Third Quarter 2023 ResultsNovember 2, 2023 | finance.yahoo.comFortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K.November 1, 2023 | morningstar.comFortrea Holdings Inc FTREOctober 27, 2023 | finance.yahoo.comThe recent drop in prices must have disappointed Fortrea Holdings Inc. (NASDAQ:FTRE) institutional investors who own 46% of the sharesOctober 18, 2023 | finance.yahoo.comHere’s Why Madison Mid Cap Fund Elected to Sell Fortrea Holdings (FTRE)October 17, 2023 | benzinga.comWhy Fortrea Holdings Shares Are Gaining TodayOctober 17, 2023 | wsj.comStocks to Watch Tuesday: Fortrea, Ericsson, J&J, Goldman SachsOctober 17, 2023 | au.investing.comFortrea gains as activist Starboard said to have built 5%+ stakeOctober 17, 2023 | msn.comActivist Starboard takes more than 5% stake in Fortrea Holdings - WSJOctober 17, 2023 | msn.comFortrea Stock (NASDAQ:FTRE): Activist Investor Starboard Snaps Up Over 5% StakeOctober 13, 2023 | finance.yahoo.comFortrea Appoints Life Science Executive Dr. John Doyle to Lead Consulting TeamOctober 11, 2023 | finance.yahoo.comFortrea Announces Date for Third Quarter 2023 Financial Results and Conference CallOctober 11, 2023 | finance.yahoo.comFortrea Announces Date for Third Quarter 2023 Financial Results and Conference CallOctober 10, 2023 | finance.yahoo.comFortrea’s Jim Cameli Named a Top 100 Global Chief Information Security Officer by HotTopicsOctober 6, 2023 | finance.yahoo.comHere’s Why Vltava Fund Sold Fortrea Holdings (FTRE)September 16, 2023 | finance.yahoo.comBased On Its ROE, Is Fortrea Holdings Inc. (NASDAQ:FTRE) A High Quality Stock?See More Headlines Receive FTRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fortrea and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/13/2023Today12/05/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/12/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Medical laboratories Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:FTRE CUSIPN/A CIK1965040 Webwww.fortrea.com Phone877-495-0816FaxN/AEmployees19,000Year FoundedN/APrice Target and Rating Average Stock Price Target$33.25 High Stock Price Target$38.00 Low Stock Price Target$27.00 Potential Upside/Downside+7.5%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.93 Current Ratio1.62 Quick Ratio1.62 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares88,800,000Free FloatN/AMarket Cap$2.75 billion OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMs. Jill McConnell (Age 49)Chief Financial Officer Comp: $615.13kMr. Mark A. Morais (Age 47)COO & President of Clinical Services Comp: $537.45kMr. Thomas H. Pike (Age 64)CEO, President & Chairman Ms. Hima B. InguvaHead of Investor Relations & Corporate DevelopmentDr. John J. DoylePresident of ConsultingKey CompetitorsGuardant HealthNASDAQ:GHRadNetNASDAQ:RDNTViridian TherapeuticsNASDAQ:VRDNFulgent GeneticsNASDAQ:FLGTNateraNASDAQ:NTRAView All CompetitorsInsidersPeter M NeupertBought 11,000 shares on 8/23/2023Total: $278,300.00 ($25.30/share)Thomas PikeBought 20,000 shares on 8/23/2023Total: $504,600.00 ($25.23/share)View All Insider Transactions FTRE Stock Analysis - Frequently Asked Questions Should I buy or sell Fortrea stock right now? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fortrea in the last year. There are currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" FTRE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FTRE, but not buy additional shares or sell existing shares. View FTRE analyst ratings or view top-rated stocks. What is Fortrea's stock price target for 2024? 4 brokerages have issued 1-year price targets for Fortrea's shares. Their FTRE share price targets range from $27.00 to $38.00. On average, they predict the company's share price to reach $33.25 in the next twelve months. This suggests a possible upside of 7.5% from the stock's current price. View analysts price targets for FTRE or view top-rated stocks among Wall Street analysts. How have FTRE shares performed in 2023? Fortrea's stock was trading at $32.52 at the beginning of 2023. Since then, FTRE stock has decreased by 4.9% and is now trading at $30.94. View the best growth stocks for 2023 here. When is Fortrea's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, February 12th 2024. View our FTRE earnings forecast. How were Fortrea's earnings last quarter? Fortrea Holdings Inc. (NASDAQ:FTRE) issued its quarterly earnings results on Monday, November, 13th. The company reported $0.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.08. The firm earned $776.40 million during the quarter, compared to analyst estimates of $748.90 million. The company's quarterly revenue was up 1.8% compared to the same quarter last year. What ETFs hold Fortrea's stock? ETFs with the largest weight of Fortrea (NASDAQ:FTRE) stock in their portfolio include Invesco S&P Spin-Off ETF (CSD), Invesco S&P SmallCap Health Care ETF (PSCH), iShares Factors US Value Style ETF (STLV), ETFMG Treatments Testing and Advancements ETF (GERM), SPDR S&P 600 Small CapValue ETF (SLYV), Global X Telemedicine & Digital Health ETF (EDOC), iShares U.S. Healthcare Providers ETF (IHF) and iShares S&P Small-Cap 600 Value ETF (IJS). How do I buy shares of Fortrea? Shares of FTRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:FTRE) was last updated on 12/6/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortrea Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.